NCT01044381View on ClinicalTrials.gov

Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Onychomycosis
Interventions
DRUG

Luliconazole Solution, 10%

28 days of daily application

Trial Locations (1)

77840

J&S Studies, College Station

Sponsors
All Listed Sponsors
lead

Topica Pharmaceuticals

INDUSTRY

NCT01044381 - Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis | Biotech Hunter | Biotech Hunter